• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

锥切术中进行宫颈管刮除术以预测残留的宫颈原位腺癌。

Endocervical curettage at conization to predict residual cervical adenocarcinoma in situ.

作者信息

Lea Jayanthi S, Shin Christine H, Sheets Ellen E, Coleman Robert L, Gehrig Paola A, Duska Linda R, Miller David S, Schorge John O

机构信息

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, UT Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-9032, USA.

出版信息

Gynecol Oncol. 2002 Oct;87(1):129-32. doi: 10.1006/gyno.2002.6791.

DOI:10.1006/gyno.2002.6791
PMID:12468353
Abstract

OBJECTIVE

To determine if performing an endocervical curettage (ECC) at the time of conization is a useful diagnostic tool for predicting residual cervical adenocarcinoma in situ (AIS) among women who might wish to preserve their fertility.

METHODS

All patients diagnosed with AIS from 1995 to 2000 at four institutions were identified. Data were retrospectively extracted from clinical records. Women included in the statistical analysis were (1) younger than 40 years, (2) had an ECC performed at the time of the initial cone biopsy, (3) had a clearly demarcated surgical margin pathologically, and (4) underwent a second surgical procedure.

RESULTS

Twenty-nine (24%) of 123 AIS patients met criteria for inclusion. The median age was 33 years (range, 17 to 39) and 13 (46%) were nulliparous. Initial surgery was a cold-knife conization (n = 17) or loop electrosurgical excision procedure (n = 12). Twelve (41%) ECCs and 15 (52%) cone margins were histologically positive. Sixteen patients underwent a repeat conization; 13 underwent hysterectomy. Thirteen (45%) patients had residual AIS at the time of their second surgical procedure. ECC had a superior positive predictive value (100% vs 47%; P < 0.01) and negative predictive value (94% vs 57%; P = 0.01) compared to cone margin in predicting residual AIS. None of the women undergoing fertility-sparing surgery developed recurrent AIS or adenocarcinoma.

CONCLUSION

ECC performed at the time of conization may be a useful tool for predicting residual AIS in women considering fertility preservation.

摘要

目的

确定在锥形切除术时进行宫颈管刮除术(ECC)是否是一种有用的诊断工具,用于预测可能希望保留生育能力的女性中残留的宫颈原位腺癌(AIS)。

方法

确定了1995年至2000年在四家机构诊断为AIS的所有患者。数据从临床记录中回顾性提取。纳入统计分析的女性为:(1)年龄小于40岁;(2)在初次锥形活检时进行了ECC;(3)手术切缘在病理上界限清晰;(4)接受了第二次手术。

结果

123例AIS患者中有29例(24%)符合纳入标准。中位年龄为33岁(范围17至39岁),13例(46%)未生育。初次手术为冷刀锥形切除术(n = 17)或环形电切术(n = 12)。12例(41%)ECC和15例(52%)锥形切缘组织学检查呈阳性。16例患者接受了再次锥形切除术;13例接受了子宫切除术。13例(45%)患者在第二次手术时仍有残留AIS。与锥形切缘相比,ECC在预测残留AIS方面具有更高的阳性预测值(100%对47%;P < 0.01)和阴性预测值(94%对57%;P = 0.01)。接受保留生育功能手术的女性均未发生复发性AIS或腺癌。

结论

在锥形切除术时进行ECC可能是预测考虑保留生育能力女性中残留AIS的有用工具。

相似文献

1
Endocervical curettage at conization to predict residual cervical adenocarcinoma in situ.锥切术中进行宫颈管刮除术以预测残留的宫颈原位腺癌。
Gynecol Oncol. 2002 Oct;87(1):129-32. doi: 10.1006/gyno.2002.6791.
2
Endocervical curettage, cone margins, and residual adenocarcinoma in situ of the cervix.宫颈管搔刮术、宫颈锥切切缘与宫颈原位腺癌残留
Obstet Gynecol. 1997 Jul;90(1):1-6. doi: 10.1016/S0029-7844(97)00122-1.
3
Cervical conization of adenocarcinoma in situ: a predicting model of residual disease.宫颈原位腺癌锥切:残留疾病的预测模型。
Am J Obstet Gynecol. 2014 Apr;210(4):366.e1-366.e5. doi: 10.1016/j.ajog.2013.12.030. Epub 2013 Dec 24.
4
The status and distance of cone biopsy margins as a predictor of excision adequacy for endocervical adenocarcinoma in situ.宫颈原位腺癌切除充分性预测指标:锥形活检切缘的状态与距离
Am J Clin Pathol. 1998 Jun;109(6):727-32. doi: 10.1093/ajcp/109.6.727.
5
Factors affecting residual lesion in women with cervical adenocarcinoma in situ after cone excisional biopsy.影响宫颈原位腺癌患者锥形切除活检后残留病灶的因素。
Asian Pac J Cancer Prev. 2007 Apr-Jun;8(2):225-8.
6
[Risk stratified management of cervical adenocarcinoma in situ based on cone margin state].基于锥切边缘状态的宫颈原位腺癌风险分层管理
Zhonghua Fu Chan Ke Za Zhi. 2021 Sep 25;56(9):622-629. doi: 10.3760/cma.j.cn112141-20210802-00417.
7
Risk for residual adenocarcinoma in situ or cervical adenocarcinoma in women undergoing loop electrosurgical excision procedure/conization for adenocarcinoma in situ.接受环形电切术/锥切术治疗原位腺癌的女性发生残留原位腺癌或宫颈腺癌的风险。
J Reprod Med. 2011 Sep-Oct;56(9-10):376-80.
8
Risk of residual disease and invasive carcinoma in women treated for adenocarcinoma in situ of the cervix.宫颈原位腺癌治疗后残留疾病和浸润性癌的风险。
Gynecol Oncol. 2013 Jun;129(3):513-6. doi: 10.1016/j.ygyno.2013.03.015. Epub 2013 Mar 28.
9
Conservative management of adenocarcinoma in situ of the cervix.宫颈原位腺癌的保守治疗
Gynecol Oncol. 2000 Oct;79(1):6-10. doi: 10.1006/gyno.2000.5962.
10
Fertility-sparing surgery in 101 women with adenocarcinoma in situ of the cervix.101例宫颈原位腺癌患者的保留生育功能手术
Gynecol Oncol. 2007 Nov;107(2):316-9. doi: 10.1016/j.ygyno.2007.06.021. Epub 2007 Aug 8.

引用本文的文献

1
Endocervical Curettage and Extended HPV Genotyping as Predictors of Residual Disease After Hysterectomy in Postmenopausal Women Previously Treated with LEEP for CIN3: A Multivariate Analysis.宫颈管搔刮术及扩展的人乳头瘤病毒基因分型作为绝经后妇女先前因CIN3接受LEEP治疗后子宫切除术后残留疾病的预测指标:一项多变量分析
Cancers (Basel). 2025 Jul 7;17(13):2264. doi: 10.3390/cancers17132264.
2
Pathologic Findings From Conization as Predictors of Residual Disease in Stage IA2 Cervical Cancer: Implications for Fertility-Preserving Surgery With Sentinel Lymph Node Biopsy.宫颈锥切术的病理结果作为IA2期宫颈癌残留病灶的预测指标:对保留生育功能的前哨淋巴结活检手术的意义
Cureus. 2025 Jun 9;17(6):e85651. doi: 10.7759/cureus.85651. eCollection 2025 Jun.
3
Revision of quality indicators for cervical cancer and trend analysis of existing indicators in Japan.
日本宫颈癌质量指标的修订及现有指标的趋势分析。
J Gynecol Oncol. 2025 Sep;36(5):e78. doi: 10.3802/jgo.2025.36.e78. Epub 2025 Mar 5.
4
Current state of fertility preservation for adolescent and young adult patients with gynecological cancer.妇科癌症青少年和年轻患者生育力保存的现状。
Int J Clin Oncol. 2022 Jan;27(1):25-34. doi: 10.1007/s10147-021-02063-y. Epub 2021 Nov 15.
5
2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors.2019年美国阴道镜和子宫颈病理学会基于风险的子宫颈癌筛查异常检测及癌前病变管理共识指南。
J Low Genit Tract Dis. 2020 Apr;24(2):102-131. doi: 10.1097/LGT.0000000000000525.
6
Diagnosis and Management of Adenocarcinoma in Situ: A Society of Gynecologic Oncology Evidence-Based Review and Recommendations.《原位腺癌的诊断与管理:妇科肿瘤学学会循证综述与推荐》。
Obstet Gynecol. 2020 Apr;135(4):869-878. doi: 10.1097/AOG.0000000000003761.
7
Cervical Screening Results Leading to Detection of Adenocarcinoma in Situ of the Uterine Cervix.宫颈筛查结果导致子宫颈原位腺癌的检出
Asian Pac J Cancer Prev. 2019 Feb 26;20(2):377-382. doi: 10.31557/APJCP.2019.20.2.377.
8
Guidelines for HPV-DNA Testing for Cervical Cancer Screening in Brazil.巴西宫颈癌筛查HPV-DNA检测指南
Rev Bras Ginecol Obstet. 2018 Jun;40(6):360-368. doi: 10.1055/s-0038-1657754. Epub 2018 Jun 6.
9
Oncological and reproductive outcomes of adenocarcinoma in situ of the cervix managed with the loop electrosurgical excision procedure.宫颈原位腺癌行环形电切术的肿瘤学和生殖结局。
BMC Cancer. 2018 Apr 24;18(1):461. doi: 10.1186/s12885-018-4386-6.
10
Atypical Papanicolaou smear in pregnancy.孕期非典型巴氏涂片
Clin Med Res. 2005 Feb;3(1):13-8. doi: 10.3121/cmr.3.1.13.